Ion Beam Applications SA (IBAB.BR)
EUR 13.06
(1.08%)
EUR 13.06
(1.08%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -67.72 Million EUR | 46.66% |
| 2022 | -126.95 Million EUR | 3.52% |
| 2021 | -131.59 Million EUR | -90.56% |
| 2020 | -69.05 Million EUR | -424.4% |
| 2019 | 21.28 Million EUR | -56.9% |
| 2018 | 49.38 Million EUR | 219.09% |
| 2017 | 15.47 Million EUR | 134.65% |
| 2016 | -44.66 Million EUR | 10.75% |
| 2015 | -50.04 Million EUR | -843.99% |
| 2014 | -5.3 Million EUR | -129.24% |
| 2013 | 18.13 Million EUR | -35.86% |
| 2012 | 28.26 Million EUR | -34.43% |
| 2011 | 43.11 Million EUR | 57.91% |
| 2010 | 27.3 Million EUR | 343.45% |
| 2009 | -11.21 Million EUR | 37.02% |
| 2008 | -17.8 Million EUR | 44.4% |
| 2007 | -32.02 Million EUR | 27.2% |
| 2006 | -43.99 Million EUR | -140.45% |
| 2005 | -18.29 Million EUR | 20.67% |
| 2004 | -23.06 Million EUR | -253.84% |
| 2003 | 14.99 Million EUR | -88.79% |
| 2002 | 133.68 Million EUR | -31.68% |
| 2001 | 195.67 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -27.74 Million EUR | 0.0% |
| 2023 FY | -67.72 Million EUR | 46.66% |
| 2023 Q2 | -61.72 Million EUR | 0.0% |
| 2023 Q4 | -67.72 Million EUR | 0.0% |
| 2022 FY | -126.95 Million EUR | 3.52% |
| 2022 Q2 | -137.59 Million EUR | 0.0% |
| 2022 Q4 | -126.95 Million EUR | 0.0% |
| 2021 Q4 | -131.59 Million EUR | 0.0% |
| 2021 Q2 | -68.5 Million EUR | 0.0% |
| 2021 FY | -131.59 Million EUR | -90.56% |
| 2020 Q4 | -69.05 Million EUR | 0.0% |
| 2020 FY | -69.05 Million EUR | -424.4% |
| 2020 Q2 | -3.76 Million EUR | 0.0% |
| 2019 Q2 | 72.29 Million EUR | 0.0% |
| 2019 FY | 21.28 Million EUR | -56.9% |
| 2019 Q4 | 21.28 Million EUR | 0.0% |
| 2018 Q2 | 39.08 Million EUR | 0.0% |
| 2018 FY | 49.38 Million EUR | 219.09% |
| 2018 Q4 | 49.38 Million EUR | 0.0% |
| 2017 Q4 | 15.47 Million EUR | 0.0% |
| 2017 FY | 15.47 Million EUR | 134.65% |
| 2017 Q2 | -21.16 Million EUR | 0.0% |
| 2016 Q2 | -58.54 Million EUR | 0.0% |
| 2016 FY | -44.66 Million EUR | 10.75% |
| 2016 Q4 | -44.66 Million EUR | 0.0% |
| 2015 FY | -50.04 Million EUR | -843.99% |
| 2015 Q2 | -20.65 Million EUR | 0.0% |
| 2015 Q4 | -50.04 Million EUR | 0.0% |
| 2014 FY | -5.3 Million EUR | -129.24% |
| 2014 Q4 | -5.3 Million EUR | 0.0% |
| 2014 Q2 | -10.81 Million EUR | 0.0% |
| 2013 Q2 | 62.38 Million EUR | 0.0% |
| 2013 Q4 | 18.13 Million EUR | 0.0% |
| 2013 FY | 18.13 Million EUR | -35.86% |
| 2012 Q2 | 42.55 Million EUR | 0.0% |
| 2012 Q4 | 28.26 Million EUR | 0.0% |
| 2012 FY | 28.26 Million EUR | -34.43% |
| 2011 Q4 | 43.11 Million EUR | 0.0% |
| 2011 FY | 43.11 Million EUR | 57.91% |
| 2011 Q2 | 2.87 Million EUR | 0.0% |
| 2010 Q2 | 45.61 Million EUR | 0.0% |
| 2010 FY | 27.3 Million EUR | 343.45% |
| 2010 Q4 | 27.3 Million EUR | 0.0% |
| 2009 FY | -11.21 Million EUR | 37.02% |
| 2009 Q4 | -11.21 Million EUR | 0.0% |
| 2008 FY | -17.8 Million EUR | 44.4% |
| 2007 FY | -32.02 Million EUR | 27.2% |
| 2006 FY | -43.99 Million EUR | -140.45% |
| 2005 FY | -18.29 Million EUR | 20.67% |
| 2004 FY | -23.06 Million EUR | -253.84% |
| 2003 FY | 14.99 Million EUR | -88.79% |
| 2002 FY | 133.68 Million EUR | -31.68% |
| 2001 FY | 195.67 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Affluent Medical SA | 15.47 Million EUR | 537.6% |
| Bluelinea Société Anonyme | -870.82 Thousand EUR | -7676.86% |
| Carmat SA | 49.63 Million EUR | 236.439% |
| Diagnostic Medical Systems S.A. | 11.52 Million EUR | 687.465% |
| Euromedis Groupe | -8.82 Million EUR | -667.3% |
| Eurobio Scientific Société anonyme | 51.33 Million EUR | 231.929% |
| Ikonisys S.A. | 3.19 Million EUR | 2217.602% |
| Implanet S.A. | 5.9 Million EUR | 1247.264% |
| Median Technologies SA | 3.5 Million EUR | 2031.631% |
| SpineGuard SA | 215.79 Thousand EUR | 31482.735% |
| Theraclion SA | -5.86 Million EUR | -1054.789% |
| Euroapi S.A. | 191 Million EUR | 135.457% |
| Guerbet SA | 332.59 Million EUR | 120.362% |
| Koninklijke Philips N.V. | 5.82 Billion EUR | 101.164% |
| Sequana Medical NV | 14.2 Million EUR | 576.828% |